相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study
Patrick A. Ott et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer et al.
LANCET (2017)
Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer
S. H. Lim et al.
EUROPEAN JOURNAL OF CANCER (2016)
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Kei Muro et al.
LANCET ONCOLOGY (2016)
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
Scott J. Antonia et al.
LANCET ONCOLOGY (2016)
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
Corey J. Langer et al.
LANCET ONCOLOGY (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Assessment of the PD-L1 status by immunohistochemistry: challenges and perspectives for therapeutic strategies in lung cancer patients
Marius Ilie et al.
VIRCHOWS ARCHIV (2016)
Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells
Anja Derer et al.
FRONTIERS IN IMMUNOLOGY (2016)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Comparison of Chemotherapeutic Treatment Outcomes of Advanced Extrapulmonary Neuroendocrine Carcinomas and Advanced Small-Cell Lung Carcinoma
T. Terashima et al.
NEUROENDOCRINOLOGY (2012)
Should Extrapulmonary Small Cell Cancer Be Managed Like Small Cell Lung Cancer?
Sinead M. Brennan et al.
CANCER (2010)
The epidemiology and survival of extrapulmonary small cell carcinoma in South East England, 1970-2004
Yien Ning S. Wong et al.
BMC CANCER (2009)
Clinical and therapeutic aspects of extrapulmonary small cell carcinoma
Annemiek M. E. Walenkamp et al.
CANCER TREATMENT REVIEWS (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Limited-stage extrapulmonary small cell carcinoma: Outcomes after modern chemotherapy and radiotherapy
Daniel E. Soto et al.
CANCER JOURNAL (2007)
Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer
Mary E. R. O'Brien et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Extrapulmonary small-cell carcinoma: a single-institution experience
JH Kim et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2004)
Extrapulmonary small cell carcinoma: Multimodality treatment results
M Sengoz et al.
TUMORI (2003)
分享论文
